Prometic

Prometic

Prometic

ProMetic is a global biopharmaceutical company offering technologies for largescale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens.
Raised
$119.5M
Follow us
Alexa global traffic share
Latest funding Show all
$80,000,000
Debt financing - 2017
Thomvest Asset Management
$9,500,000
Post-IPO equity - 2017
Team Size
50+
Employees
Location
Headquarters
$80,000,000 Debt financing
PE HUB

Thomvest gives Prometic access to $100 mln line of credit

$9,500,000 Post-IPO equity
biospace

ProMetic Life Sci Receives 9 5 Million Purchase Order From Multinational Client

PE HUB

Prometic to raise additional $25 mln from Thomvest vehicle

Funding Stock markets
Private equity
PE HUB

California Capital Equity ups equity stake in ProMetic Life Sciences

Funding Science
$30,000,000 Debt financing
FierceBiotech

ProMetic raises $30 million